What Are Peptides? How They Differ From Proteins, Hormones, and Small Molecules in Structure, Size, and Function

What Defines a Peptide?

At the most fundamental level, peptides are short chains of amino acids typically containing between 2 and 50 residues linked by peptide bonds. These bonds form through a condensation reaction between the carboxyl group of one amino acid and the amino group of the next. The result is a linear or cyclic chain that, while chemically related to proteins, occupies a distinct category in biochemistry.

Most peptides have molecular weights ranging from approximately 200 to 5,000 daltons, placing them between small molecules and proteins in size. This intermediate position gives peptides a unique pharmacological profile: they are large enough to interact with biological targets with high specificity, yet small enough to be synthesised efficiently using solid-phase peptide synthesis (SPPS) and other laboratory methods.

The Peptide Register glossary provides definitions for many of the technical terms used throughout peptide science, including peptide bond, amino acid residue, and molecular weight.

How Peptides Differ From Proteins

The boundary between peptides and proteins is not absolute, but the conventional threshold sits at roughly 50 amino acids. Proteins generally contain more than 50 amino acids and adopt complex three-dimensional structures including tertiary and quaternary folding. These higher-order structures are essential to protein function; enzymes, antibodies, and structural proteins like collagen all depend on precise folding to perform their biological roles.

Peptides, by contrast, tend to exist as linear or simple cyclic chains. They may form secondary structures such as alpha-helices or beta-turns, but they rarely exhibit the elaborate folding seen in proteins. This structural simplicity affects how peptides interact with biological systems. While proteins often function through conformational changes and multi-site binding, peptides typically act as ligands that bind a single receptor site.

Insulin, a 51-amino-acid peptide hormone, is one of the most well-known examples that sits at the boundary between peptide and protein classification. Some sources classify it as a small protein; others treat it as a large peptide. This ambiguity illustrates the point that the peptide-protein boundary is a convention, not a rigid rule.

Peptides, Hormones, and the Overlap

Not all peptides are hormones, and not all hormones are peptides. Hormones are defined by their function: they are signalling molecules produced by endocrine glands that travel through the bloodstream to act on distant target tissues. Hormones can be peptides, steroids, or amino acid derivatives.

Peptide hormones such as oxytocin and vasopressin contain only 9 amino acids each and function as endocrine signalling molecules. Growth hormone-releasing hormone (GHRH), glucagon, and somatostatin are also peptide hormones. Steroid hormones like testosterone and cortisol, by contrast, are derived from cholesterol and have an entirely different chemical structure.

Understanding this overlap matters for regulatory and research purposes. Some peptides studied in research contexts, such as growth hormone secretagogues like CJC-1295 and ipamorelin, are investigated for their ability to stimulate endogenous hormone release. For more on these specific compounds, the Peptide Register has published a detailed overview of CJC-1295 and ipamorelin research. Regulatory classification of peptides varies significantly by jurisdiction, with some peptides scheduled as prescription-only medicines in Australia and the EU.

Peptides vs Small Molecules: Size, Permeability, and Pharmacology

Small molecules typically have a molecular weight below 900 daltons and can often cross cell membranes by passive diffusion. This property makes small-molecule drugs like aspirin, metformin, and ibuprofen effective when taken orally. They can reach intracellular targets directly.

Peptides generally cannot cross cell membranes passively and instead bind to extracellular receptors on the cell surface. This limits their intracellular access but often provides high target selectivity and lower off-target toxicity compared to small molecules. However, it also creates pharmacological challenges. Oral bioavailability of most peptides remains low due to enzymatic degradation in the gastrointestinal tract and poor membrane permeability. This is why many peptide-based therapeutics require injection, and why research into alternative delivery routes, including nasal, transdermal, and oral formulations with permeation enhancers, remains active. The Peptide Register has covered how different delivery methods compare in terms of bioavailability.

Despite these challenges, the global peptide therapeutics market includes more than 80 peptide-based drugs approved by the FDA as of 2024. These span indications from diabetes management (e.g., semaglutide, liraglutide) to oncology, cardiovascular medicine, and rare diseases. Each approved peptide drug has undergone rigorous clinical evaluation, including phase III randomised controlled trials and post-marketing surveillance.

Why These Distinctions Matter

For researchers and clinicians, correctly classifying a molecule as a peptide, protein, hormone, or small molecule has practical consequences. Classification affects regulatory pathways, manufacturing requirements, stability considerations, storage conditions, and routes of administration. A molecule classified as a biologic, for instance, faces different approval standards than a small-molecule drug.

The Peptide Register catalogues peptides by category with structured profiles covering mechanism of action, published evidence, and regulatory status. Explore the full peptide database for individual compound profiles.

These distinctions also matter when evaluating published research. Understanding whether a study compound is a naturally occurring peptide hormone, a synthetic analogue, or a novel research peptide helps readers assess the relevance and translatability of findings. For guidance on critically appraising peptide studies, see the Peptide Register's guide on how to read peptide research.